However, the transfer of regulatory immune components may not be the only driver of protection from allergies; for example, maternal interferon gamma (IFN-γ) (which is produced in response to numerous type 1 immunity-related infections) was demonstrated to protect against experimental allergies in offspring [80]. Here, IFNG is linked to allergic disease.